Comparison

ONCOassist vs Iylon

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

ONCOassist

This app provides oncology professionals with a comprehensive suite of decision-support tools. It offers access to treatment protocols, survival rates, medical calculators, toxicity criteria, staging information, drug details, and news, all designed to aid in patient care and save time.

Highlights
  • NCCN Treatment Protocols
  • Adjuvant Survival Rate Calculators
  • Medical Formula Calculators
  • CTCAE Toxicity Criteria
  • AJCC TNM Staging
  • Prognostic Scores
  • Oncology Drug Information
  • Drug Interaction Checker
Features
Read full description

Please note: This application, as a decision-support aid, is to be used  by a practicing healthcare professional(“HCP”) and does not replace clinical judgement. It is not designed for use by patients and does not replace the advice of a doctor. ONCOassist is a comprehensive suite of decision support tools developed by oncology professionals, for oncology professionals. It includes a range of breakthrough tools designed to manage patient care effectively. Let's take a closer look at some of the features available: • NCCN Treatment Protocols: Developed in collaboration with the NCCN, this tool provides information on regimens taken from the NCCN template database. • Adjuvant Tools: These tools offer 5 and 10-year overall survival rates for patients with and without chemotherapy in an adjuvant setting. Breast cancer, colon cancer, and GIST tools are among the many adjuvant decision support tools available. • Useful formulas: Body Surface Area, Chemotherapy Dose Calculator, QTc, ECOG Performance Score, Khorana Score, MASCC Risk Index, and many more are included. These calculators simplify medical calculations and include frequently needed conversions and dosage calculations. • Common Toxicity Criteria for Adverse Events (CTCAE v4.0 & 5.0): This tool provides a standardized classification of adverse effects of drugs used in cancer therapy. CTCAE versions 5.0 and 4.0 are available in an easy-to-use and interactive format. • AJCC TNM staging: The tool provides criteria for every malignancy and includes the AJCC 7th, 8th, and 9th edition staging criteria. • Prognostic Scores: This tool offers over 17 prognostic scores for a range of specialties. It helps with prognostication, risk stratification, and determining eligibility for specific treatments or clinical trials. • Drug info section: Over 200 oncology drugs are available in an easy-to-use and interactive format. • Drug interaction checker: This tool helps users quickly check for potential drug interactions. • IO toxicity management tool: This tool is designed to manage immune-related adverse events. • ONCOnews: From breaking news to in-depth analysis, ONCOnews brings together all oncology news sources in one place. • ONCOvideos: This offers access to the most recent videos from Oncology Spotlight, which provides insights into the experiences of oncology professionals. Additionally, users can watch OncoAlert and Oncology Brother videos. ONCOassist offers oncology professionals the following benefits: Saves Time Oncology professionals no longer waste time searching through the internet for safe validated information to aid them with their decision making, all of the tools and information they need is available within ONCOassist and is available without the need for internet access. Improves quality of care ONCOassist promotes the use of evidence-based medicine. It is also the only CE approved oncology app on the market. Helps Empower Patients Adjuvant decision support tools contain patient-friendly information to allow for a more collaborative decision-making process. Regularly updating ONCOassist will be updated regularly with new prognostic tools and calculators. We will listen to your feedback and update accordingly. Email us at any time using feedback@oncoassist.com. ONCOassist is regulated by the Irish Health Products Regulatory Authority and is CE marked for conformance as a medical device.

About

Iylon

Features
Read full description

Iylon connects patients, their clinicians and specialist oncology advisors to review complex cancer cases, wherever they are. With the Iylon app you can: • Submit a case in minutes Share your diagnosis details, medical records, scans and reports securely from your iPhone or iPad. Take photos of documents with your camera or upload files you already have. • Track every case See where each case stands, from submission and advisor review to the final recommendation, with a clear timeline for every step. • Read your recommendation report Open the specialist's recommendation report directly in the app, download it, and share it with your own doctor. • Talk to your care team Message the Iylon care team about a case and ask follow-up questions after your report is shared. • Get notified when it matters Turn on optional notifications to hear the moment your case moves forward, a report is ready or the care team replies. You can switch them off at any time in Settings. • Secure sign-in Use the same account you use on iylon.com. Every sign-in is confirmed with a one-time code sent to your email or phone, and you can add Face ID or Touch ID to sign in and unlock the app quickly. Built for everyone involved in the case Patients and caregivers, referring clinicians, specialist advisors and the Iylon coordination team each see the tools for their role. Your privacy Your medical information is sent over encrypted connections and is only shared with the people involved in your case. You can delete your account from Settings in the app or at iylon.com/delete-account. Important Iylon provides expert second-opinion consultations to support decisions made with your own doctor. It is not a substitute for your care team and is not for emergencies. If you have a medical emergency, contact your local emergency services immediately. Questions? Email support@iylon.com or visit iylon.com/contact.

Screenshots

ONCOassist4 screens
Iylon3 screens

Verdict

The call

The clearest difference is ads: Iylon at none against ONCOassist's shown. ONCOassist's advantage is update cadence (every 10 days vs every 2 months). On price, in-app purchases, device support and iOS requirement there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

ONCOassist ships an update every 10 days, Iylon every 2 months. The most recent releases landed on November 6, 2026 and November 7, 2026 respectively.

Scorecard2 real differences · 8 level
ONCOassist versus Iylon: the parameters behind the verdict, then further details
ParameterONCOassistIylon
PriceFreeFree
Rating4.9 (116 ratings) — better—
Positive reviews100.0% of reviews—
Number of ratings116 — better—
Update frequencyEvery 10 days — betterEvery 2 months
AdsYesNo — better
In-app purchasesNoNo
MonetizationFree with in-app purchases—
DevicesiPhone, iPad, iPod — betteriPhone, iPad
Requires iOS15.6 — better16.4
Further details — not scored
Size244 MB59 MB
Age rating17+17+
DeveloperPortable Medical Technology LtdIylon Precision Oncology

Bugs and requests

ONCOassist

Requested features

3 requests
  • Radiation oncology topics
  • Option in Spanish
  • Russian language

Iylon

Not enough reviews yet to summarise bugs or requests.

In-app purchases

None

ONCOassist

No in-app purchases

None

Iylon

No in-app purchases

Questions

Is ONCOassist free?
ONCOassist is free to download, with no in-app purchases.
Is Iylon free?
Iylon is free to download, with no in-app purchases.
Do ONCOassist or Iylon have ads?
ONCOassist shows ads; Iylon does not.
Which is updated more often, ONCOassist or Iylon?
ONCOassist ships an update every 10 days, and Iylon every 2 months. Most recently, ONCOassist was updated on November 6, 2026 and Iylon on November 7, 2026.

Other comparisons